JOIN THE PHYSIONIC INSIDERS [PREMIUM CONTENT]Join the Physionic Insiders: https://bit.ly/PhysionicInsiders2 HEALTH AUTONOMY [COURSE]Learn to Analyze & Apply Studies for Yourself: https://bit.ly/healthautonomyJOIN THE COMMUNITYJoin my Community [It’s Free!]: https://bit.ly/PhysionicCommunity2EMAIL LIST1-2 Weekly Email of Value [It’s Free!]: http://bit.ly/2AXIzK6HIRE ME FOR CONSULTING: Consulting: https://bit.ly/3dmUl2H Created with Biorender0:00 - Introduction0:42 - The Cancer Preventing Effect4:49 - A more Mind-Blowing Finding!8:06 - Might not work for some?9:27 - Main PointsBerberine on Cardiovascular Disease: https://youtu.be/8k0UORw5rvY?si=n2bqFyYtV7MOvAA9A Potent Anti-Cancer Nutrient: https://youtu.be/mZOCHKgsjCA?si=hUBi1epUGlSF4A-NReferences[Study 550] Chen YX, Gao QY, Zou TH, et al. Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study. Lancet Gastroenterol Hepatol. 2020;5(3):267-275. doi:10.1016/S2468-1253(19)30409-1Funding/Conflicts: Public Funding: This study was supported by the National Natural Science Foundation of China (grants 81421001, 81530072, 81830081, and 8177100232), Shanghai Shenkang Hospital Development Center (SHDC12018121), Shanghai Municipal Key Clinical Specialty, the Top-Notch project of China, and the Shanghai Municipal Education Commission–Gaofeng Clinical Medicine Grant (20152514); Non-Profit Funding: no non-profit funding sources were reported; Industry Funding: no industry funding sources were reported; Conflicts of Interest: the authors declared no competing interests.[Study 551] Tan YJ, Zou TH, Yu K, et al. Berberine for preventing colorectal adenoma recurrence and neoplasm occurrence: 6-year follow-up of a randomized clinical trial. Cell Rep Med. 2025;6:102293. doi:10.1016/j.xcrm.2025.102293Funding/Conflicts: Public Funding: This study was supported by the National Natural Science Foundation of China (grants 82330086, 8220110843, 82250005, 82273140, and 82372849), the National Key R&D Program of China (2020YFA0509200), the Shanghai Shenkang Hospital Development Center (SHDC2020CR1034B), the Innovative Research Team of High-level Local University in Shanghai (SHSMU-ZDCX2021030), and grant number B23 of the 2030 plan from Shanghai Jiao Tong University (WH510272101); Non-Profit Funding: no non-profit funding sources were reported; Industry Funding: no industry funding sources were reported; Conflicts of Interest: the authors declared no competing interests.CRITIQUES, RULES, AND NOTESBe aware of the following rules before posting comments:- Please do not post summaries of the video in the comments - it damages retention on the video and YouTube is less likely to promote it (these videos cost me a lot of money to produce). Critiques of my work are welcome! Please be aware of the following notes & rules before submitting critique:Be mindful that this content is not all encompassing on the subject at hand and is self-limited for brevity to reach a wider audience. Also, be aware that I receive hundreds of YouTube comments per day, so the only way your critique can be considered is if you follow the steps outlined below. Finally, YouTube auto-deletes links, so I do not see most comments with links attached. RULES:If your comment is rude, you will be banned.If your comment is not about the studies/topics at hand (i.e. extending to other outcomes not discussed) or offers critique with no scientific basis, it is unlikely to receive a response.If you can follow these rules, I will try to address your critique and if there is merit, I will add an AMENDMENT to the content in question and pin it so everyone can see it (thank you!). Please use the following link to submit your critique: https://bit.ly/PhysionicCritiqueDisclaimer: None of the information provided by this brand is a replacement for your physician's advice. This brand is information for the sake of knowledge and the options of choice it provides, not in any way a personalized prescription. Please consult your physician before making any health related changes.